ZALSENERTANT TETRAXETAN
UNII XF82V61Y8U

Substance Identification & Data

This profile provides standardized clinical and technical data for Zalsenertant Tetraxetan, uniquely identified by the FDA Unique Ingredient Identifier (UNII) XF82V61Y8U.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1613265-38-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
XF82V61Y8U
CAS Registry Number
1613265-38-5
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
ZALSENERTANT TETRAXETAN
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C58H84N10O13
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
NQKDJWKHSVVCRZ-UHFFFAOYSA-N
Line notation for describing the chemical structure and connectivity of atoms.
NCI Thesaurus
C175878
National Cancer Institute reference terminology for clinical and research data.
PubChem CID
74766516
Unique identification number in the NCBI database of chemical substances.
INN ID
11446
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
N(C1(C2CC3CC(C2)CC1C3)C(=O)O)C(c4cc(-c5c(OC)cccc5OC)n(-c6ccc(C(=O)N(C)CCCN(C)CCCN(C)C(=O)CN7CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC7)cc6C(C)C)n4)=O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Zalsenertant Tetraxetan. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ZALSENERTANT TETRAXETAN

Common Names & Synonyms

ZALSENERTANT TETRAXETAN [INN]

Systematic Nomenclature

1,4,7,10-TETRAAZACYCLODODECANE-1,4,7-TRIACETIC ACID, 10-(2-((3-((3-((4-(3-(((2-CARBOXYTRICYCLO(3.3.1.13,7)DEC-2-YL)AMINO)CARBONYL)-5-(2,6-DIMETHOXYPHENYL)-1H-PYRAZOL-1-YL)-3-(1-METHYLETHYL)BENZOYL)METHYLAMINO)PROPYL)METHYLAMINO)PROPYL)METHYLAMINO)-2-OXOETHYL)-
10-(2-((3-((3-((4-(3-(((2-CARBOXYTRICYCLO(3.3.1.13,7)DEC-2-YL)AMINO)CARBONYL)-5-(2,6-DIMETHOXYPHENYL)-1H-PYRAZOL-1-YL)-3-(1-METHYLETHYL)BENZOYL)METHYLAMINO)PROPYL)METHYLAMINO)PROPYL)METHYLAMINO)-2-OXOETHYL)-1,4,7,10-TETRAAZACYCLODODECANE-1,4,7-TRIACETIC ACID

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus
NLM
PubChem Compound